SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,128.98 -276.04
(-0.56%)

Dow Jones

6,938.97 4.62
(0.07%)

Hang Seng

53,831.56 142.67
(0.27%)

Nikkei 225

10,138.52 -11.53
(-0.11%)

Forex

USD-INR

91.58 0.09
(0.10%)

EUR-INR

107.27 0.14
(0.13%)

GBP-INR

123.20 0.33
(0.27%)

JPY-INR

0.58 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506197

INE416D01022

104.3299482

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BLISSGVS

21.86

1713.25

EPS(TTM)

Face Value()

Div & Yield %

7.41

0.31

Back

visagar financial services ltd

Safari Industries (India) consolidated net profit rises 58.26% in the September 2025 quarter

Nov 10,2025

Net profit of Safari Industries (India) rose 58.26% to Rs 46.94 crore in the quarter ended September 2025 as against Rs 29.66 crore during the previous quarter ended September 2024. Sales rose 16.55% to Rs 533.55 crore in the quarter ended September 2025 as against Rs 457.79 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	533.55	457.79	17
OPM %	13.88	10.46	-
PBDT	77.68	52.51	48
PBT	60.13	37.84	59
NP	46.94	29.66	58

81,537.70 -769.67 ( -0.94%)

49,128.98 -276.04 (-0.56%)

6,938.97 4.62 (0.07%)

53,831.56 142.67 (0.27%)

10,138.52 -11.53 (-0.11%)

91.58 0.09 (0.10%)

107.27 0.14 (0.13%)

123.20 0.33 (0.27%)

0.58 0.00 (-0.17%)